Medicare Enrolled

Dr. Viral Shah, M.D.

Endocrinology · Paramus, NJ
Practice pattern: Clinical Cardiology — Primarily office-based clinical cardiology
Speaking/Promotional
30 W CENTURY RD, Paramus, NJ 07652
9735358870
In practice since 2008 (18 years)
NPI: 1336318344 verify on NPPES ↗
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Shah from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Shah? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Shah

Dr. Viral Shah is an endocrinology specialist in Paramus, NJ, with 18 years of NPI registration. Based on federal Medicare data, Dr. Shah performed 1,154 Medicare services across 761 unique beneficiaries.

Between the years covered by Open Payments, Dr. Shah received a total of $57,536 from 65 pharmaceutical and/or device companies across 806 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in endocrinology. The majority of payments are for speaking programs and promotional activities, reflecting participation in industry-sponsored events. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Shah is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 18 years in practice ▲ Top 40% volume in NJ $57,536 industry payments

Medicare Practice Summary

Medicare Utilization ↗
1,154
Medicare services
Top 40% in NJ for endocrinology
761
Unique beneficiaries
$116
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~64 Medicare services per year of practice

Top procedures by volume

Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.

Procedure Volume Avg. paid Avg. submitted
Office visit, established patient (30-39 min)
A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition.
575 $110 $410
Hospital follow-up visit, high complexity
Subsequent hospital inpatient or observation care for an existing patient involving high-level medical decision making, with at least 50 minutes total time on the date of the encounter.
156 $104 $320
Office visit, established patient, complex (40-54 min)
An office or outpatient visit for an existing patient lasting between 40 and 54 minutes. This level of service is determined by the total time spent on the date of the encounter.
115 $137 $567
Initial hospital admission, high complexity
Initial hospital inpatient or observation care for a new patient involving high-level medical decision making, with at least 75 minutes total time on the date of the encounter.
115 $150 $697
New patient office visit, complex (60-74 min) 107 $184 $690
Blood glucose test using hand-held instrument
A test that measures the level of sugar in the blood using a portable device. The result helps monitor blood glucose levels.
44 $0 $2
Continuous glucose monitoring with interpretation
This procedure involves monitoring blood sugar levels in tissue fluid using a sensor placed under the skin, along with the interpretation and reporting of the results.
42 $30 $535
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.

Industry Payment Transparency

Open Payments through 2024 ↗
$57,536
Total received (2018-2024)
Avg $8,219/year across 7 years
Top 7% in NJ for endocrinology
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
65
Companies
806
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →

Payment profile

Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.

Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$39,094 (67.9%)
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$10,466 (18.2%)
Consulting
Expert advisory fees, typically reflecting recognized clinical expertise
$7,976 (13.9%)

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$3,718
2023
$1,455
2022
$14,130
2021
$12,985
2020
$12,803
2019
$7,889
2018
$4,556

Payments by company (2024)

Consulting
Speaking
Meals & Travel
Research
Dexcom, Inc.
$2,012
Medtronic, Inc.
$240
Amgen Inc.
$212
Lilly USA, LLC
$209
Tandem Diabetes Care, Inc.
$130
Corcept Therapeutics
$87
Antares Pharma, Inc.
$87
ABBVIE INC.
$82
Amneal Pharmaceuticals LLC
$67
Abbott Laboratories
$64
SANOFI-AVENTIS U.S. LLC
$53
Intra-Sana Laboratories
$46
Bayer Healthcare Pharmaceuticals Inc.
$40
Xeris Pharmaceuticals, Inc.
$39
Radius Health, Inc.
$33
Verity Pharmaceuticals Inc.
$33
RECORDATI_RARE_DISEASES_INC.
$31
Mannkind Corporation
$31
Acella Pharmaceuticals, LLC
$28
Novo Nordisk Inc
$26
Astellas Pharma US Inc
$21
CeQur Corporation
$20
IBSA Pharma Inc.
$20
Insulet Corporation
$17
Alexion Pharmaceuticals, Inc.
$16
Kyowa Kirin, Inc.
$16
Echosens North America, Inc.
$16
Neurocrine Biosciences, Inc.
$15
Chiesi USA, Inc.
$15
AstraZeneca Pharmaceuticals LP
$14
Top 3 companies account for 66.3% of 2024 payments
All-time payments by company (2018-2024) ›
AstraZeneca Pharmaceuticals LP
$19,975
Dexcom, Inc.
$13,997
DEXCOM, INC.
$7,976
Janssen Pharmaceuticals, Inc
$5,351
Novo Nordisk Inc
$1,379
Lilly USA, LLC
$1,193
Amgen Inc.
$986
Corcept Therapeutics
$686
Amneal Pharmaceuticals LLC
$656
Abbott Laboratories
$600
SANOFI-AVENTIS U.S. LLC
$594
Medtronic, Inc.
$344
AbbVie, Inc.
$337
Mannkind Corporation
$279
Insulet Corporation
$263
Antares Pharma, Inc.
$249
Merck Sharp & Dohme Corporation
$212
Xeris Pharmaceuticals, Inc.
$189
Boehringer Ingelheim Pharmaceuticals, Inc.
$178
Radius Health, Inc.
$134
Tandem Diabetes Care, Inc.
$130
Esperion Therapeutics, Inc.
$125
Aytu BioScience, Inc
$121
CeQur Corporation
$117
ABBVIE INC.
$111
Bayer Healthcare Pharmaceuticals Inc.
$76
Intra-Sana Laboratories
$73
Merck Sharp & Dohme LLC
$72
IBSA Pharma Inc.
$62
Zealand Pharma US, Inc.
$62
VIVUS, Inc.
$60
Astellas Pharma US Inc
$60
Medtronic MiniMed, Inc.
$60
Supernus Pharmaceuticals, Inc.
$52
Kyowa Kirin, Inc.
$49
Alexion Pharmaceuticals, Inc.
$48
Gemini Laboratories, LLC
$45
Valeritas, Inc.
$45
Embecta Corp.
$42
Amryt Pharma Holdings Ltd
$40
PFIZER INC.
$39
Ascendis Pharma Inc
$35
Verity Pharmaceuticals Inc.
$33
RECORDATI_RARE_DISEASES_INC.
$31
Acella Pharmaceuticals, LLC
$28
Horizon Therapeutics plc
$28
Amarin Pharma Inc.
$26
EISAI INC.
$24
Genentech USA, Inc.
$24
Novartis Pharmaceuticals Corporation
$24
Echosens North America, Inc.
$20
Currax Pharmaceuticals LLC
$17
Azurity Pharmaceuticals, Inc.
$15
MannKind Corporation
$15
AbbVie Inc.
$15
Neurocrine Biosciences, Inc.
$15
Chiesi USA, Inc.
$15
Becton, Dickinson and Company
$15
Kowa Pharmaceuticals America, Inc.
$14
Ultragenyx Pharmaceutical Inc.
$14
LifeScan, Inc.
$13
Clarus Therapeutics Inc.
$13
Aytu Bioscience, Inc
$13
Allergan Inc.
$12
Eisai Inc.
$12
Top 3 companies account for 72.9% of all-time payments
Associated products mentioned in payments ›
AFREZZA · Adthyza · Androgel · BAQSIMI · BASAGLAR · BD Nano 2nd Gen Pen Needle · BD Ultra-Fine · BELSOMRA · BYSTOLIC · Belviq · CONTRAVE · CRYSVITA · CeQur Simplicity · Creon · Crysvita · DEXCOM CGM · DEXCOM G6 TRANSMITTER · Dexcom CGM · Dexcom G6 Transmitter · EVENITY · FARXIGA · FORTEO · FREESTYLE INSULINX · FREESTYLE LIBRE · FREESTYLE LIBRE 2 · FREESTYLE LIBRE 3 · FibroScan · FreeStyle Libre · FreeStyle Libre 2 · FreeStyle Libre blood glucose Flash Monitoring System · GVOKE HYPOPEN · GVOKE PFS · HUMALOG · HUMULIN · INVOKANA · InPen · JANUVIA · JARDIANCE · JATENZO · Kerendia · Korlym · LEQVIO · LICART · LIVALO · Lenvima · MINIMED 780G · MOUNJARO · MYALEPT · MYCAPSSA · Minimed 670G System · NEXLIZET · NOCDURNA · NP Thyroid 60 · Natesto · OTREXUP · Omnipod · OneTouch · Otrexup · Ozempic · PRALUENT · Prolia · QSYMIA · RECORLEV · RELTONE 200 MG · RYBELSUS · Repatha · Rybelsus · SIGNIFOR LAR · SOLIQUA · SOLIQUA 100/33 · SOMAVERT · STEGLATRO · STEGLUJAN · STRENSIQ · SYNTHROID · Saxenda · Synthroid · TEPEZZA · TOUJEO · TRADJENTA · TRULICITY · TZIELD · Tirosint · Tlando · Tresiba · Tymlos · UNITHROID · V-GO · Vascepa · Veozah · Victoza · Wegovy · XARELTO · XYOSTED · Xultophy 100/3.6 · ZEGALOGUE · ZEPBOUND · t:slim X2 Insulin Pump with Control-IQ
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →

The majority of payments (68%) are for speaking programs and promotional activities, which reflect participation in industry-sponsored educational or marketing events. This is common in endocrinology and does not inherently indicate bias, but patients may wish to be aware. Total industry engagement is in the top 7% for endocrinology in NJ.

Looking for an endocrinology specialist in Paramus?
Compare endocrinologists in the Paramus area by procedure volume, costs, and industry payment transparency.
Browse endocrinologists nearby

Geographic Context

Endocrinologists within 10 mi
629
Per 100K population
65.9
County median income
$123,715
Nearest hospital
VALLEY HOSPITAL
0.0 mi

Data Sources

Provider Registry NPPES Weekly updates
Medicare Enrollment PECOS Monthly updates
Practice Data Medicare Util. Annual (CY lag)
Industry Payments Open Payments CY 2024
Disciplinary History — Not public N/A

This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →

Summary

Dr. Shah is a clinical cardiology specialist, with moderate Medicare volume, with speaking/promotional industry engagement in the top 7% of NJ peers, with 18 years of NPI registration.

This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →

Frequently Asked Questions

Is Dr. Shah experienced with office visit, established patient (30-39 min)?
Based on Medicare claims data, Dr. Shah performed 575 office visit, established patient (30-39 min) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Shah receive payments from pharmaceutical companies?
Yes. Dr. Shah received a total of $57,536 from 65 companies across 806 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Shah's costs compare to other endocrinologists in Paramus?
Dr. Shah's average Medicare payment per service is $116. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Shah) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
About this page

All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Payments from industry are legal and do not indicate wrongdoing. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →